Reply to Ambrosioni et al
Clin Infect Dis
.
2019 May 17;68(11):1977-1978.
doi: 10.1093/cid/ciy1022.
Authors
Huldrych F Günthard
1
,
Vincent Calvez
2
,
Roger Paredes
3
,
Deenan Pillay
4
5
,
Robert W Shafer
6
,
Annemarie M Wensing
7
,
Donna M Jacobsen
8
,
Douglas D Richman
9
10
Affiliations
1
University Hospital Zürich and Institute of Medical Virology, University of Zurich, Switzerland.
2
Pierre et Marie Curie University and Pitié-Salpêtrieŕe Hospital, Paris, France.
3
Infectious Diseases Service and IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
4
Africa Health Research Institute, KwaZulu Natal, South Africa.
5
University College London, United Kingdom.
6
Stanford University Medical School, California.
7
University Medical Center Utrecht, The Netherlands.
8
International Antiviral Society-USA, San Francisco.
9
Veterans Affairs San Diego Healthcare System.
10
University of California San Diego.
PMID:
30520997
DOI:
10.1093/cid/ciy1022
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents*
Drug Resistance
HIV
HIV Infections*
Humans
Societies
Substances
Antiviral Agents